GET THE APP

Newer Drugs in the Management of Copd

Research and Reviews in Psychology.

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Newer Drugs in the Management of Copd

Chronic obstructive pulmonary disease is widespread throughout the world, especially in developing countries. It is a disorder of the lung characterized by airflow obstruction, inflammation and tissue remodeling. Management of patients with COPD is complex and so treatment strategies are an important issue. The pharmacological treatment of chronic obstructive pulmonary disease (COPD) is offered in a variety of new single, double and triple therapies. These include short-acting beta-2 agonists, long-acting beta-2 agonists, short-acting muscarinic antagonists, long-acting muscarinic antagonists, or inhaled corticosteroids.

Special Features

Full Text

View

Track Your Manuscript

Media Partners

Associations